PROVIDENCE – CVS Health Corp. has entered an underwriting agreement to sell $3 billion in outstanding notes. In its filing with the U.S. Securities and Exchange Commission on Dec. 3, CVS Health has agreed to sell the underwriters $.2.25 billion aggregate principal amount of its 7% Series A Junior Subordinated Notes due 2055 and $750
Already a Subscriber? Log in
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber
- Critical RI business news and analysis updated daily.
- 1 year of print (26 issues).
- Unlimited access to all subscriber only content on our website, on any device.
- Free email alerts.
- Annual Book of Lists Print Edition.
- All special issues produced during subscription term.
Click Here to purchase a paywall bypass link for this article
PBN Branded Content
Everyone needs science. Science needs everyone.
The Amgen Foundation is guided by the belief that all students should have the opportunity…
Learn More
